Search Results

Serum Institute of India Pvt. Ltd., part of Cyrus Poonawalla Group, launched gender neutral HPV vaccine that targets HPV strains 70 per cent of cervical cancer cases globally

The Supreme Court rejected Universal Health Organisation’s PIL questioning India’s HPV vaccination programme

The Delhi High Court issues notice on PIL raising concerns over HPV vaccination programme for girls.

HPV vaccine saves lives and reduces cervical cancer risk, but sustained public trust is crucial to maintain its long-term success.

A study by the American Cancer Society found states with higher vaccination rates saw a faster decline in cervical cancer risk.

New Government Initiative Aims to Reduce Cervical Cancer Burden